Viking Therapeutics, Inc.
Industry: Life Sciences ・ $VKTX on Nasdaq
Insider Sale
+$715,850
-52.02%
Shares
Shares Volume: 10,300 Shares
Average Share Price: $69.5
INSIDER
SINGLETON J MATTHEW
Director
reported on Sep 20 2024
traded on Sep 20 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT | 9,500 |
PURCHASES/SALES 1Y | 0 / 4 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $829,478.71 |
INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
PURCHASES/SALES 1Y | 0 / 19 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $3,957,336.09 |
COMPANY PREVIOUS TRADES |